Table 1 Demographics and clinical characteristics of the study population (n = 485)
Age (years): median (IQR) | 70 (58–82) |
Gender (male): n (%) | 301 (62.1%) |
BMI (kg/m2): median (IQR) | 19.4(16.4–23) |
Smoking status: n (%) | |
Current smoker | 95 (19.6%) |
Ex- smoker | 94 (19.4%) |
Never | 296 (61%) |
Previous history of PTB: n (%) | 167 (34.4%) |
Active PTB: n (%) | 3 (0.6%) |
Co-morbidities (pulmonary): n (%) | |
Bronchiectasis | 139 (28.7%) |
COPD | 69 (14.2%) |
Asthma | 32 (6.6%) |
Pulmonary fibrosis | 18 (3.7%) |
Co-morbidities (non- pulmonary): n (%) | |
Hypertension | 156 (32.2%) |
Hyperlipidaemia | 125 (25.8%) |
Diabetes mellitus | 87 (17.9%) |
Coronary artery disease | 63 (12.9%) |
HIV infection | 52 (10.7%) |
Psychiatry disorder | 38 (7.8%) |
Malignancy | 29 (6%) |
Cerebrovascular disease | 23 (4.7%) |
Chronic renal impairment | 16 (3.3%) |
Rheumatoid arthritis | 11 (2.2%) |
Prevalence of isolates per 100,000 hospital admissions | 511/100,000 |